Preparation method of 5-halogenated azaindole
By simplifying the preparation process of 5-halogenated azaindole under the catalysis of inorganic alkali or alkaline salts, reducing the reaction under alkaline conditions, solving the problem of long process routes and wastewater in the prior art, achieving high yields and High-quality product preparation reduces production costs and achieves green and environmental protection in industrial production.
Patent Information
- Application Number
- CN202411027175.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-15
AI Technical Summary
The existing 5-halogenated azaindole preparation method has problems such as long process routes, low yields, the use of a large number of strong acids and strong alkalis, and the production of a large amount of alkaline wastewater, resulting in poor product quality and high production costs.
The reaction is carried out under catalysis of inorganic alkali or alkaline salt to reduce the amount of alkali, and the second step of the reaction is carried out under dilute acid conditions to avoid polymerization under alkaline conditions, simplify the process flow, and improve product yield and quality.
The high yield and high quality preparation of 5-halogenated azaindole is achieved, which reduces the generation of alkaline wastewater, simplifies the process flow, reduces production costs, and achieves green and environmental protection for industrial production.
Smart Images

Figure BDA0004969376280000011 
Figure BDA0004969376280000012 
Figure BDA0004969376280000021
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of organic synthesis, and in particular to a method for preparing 5-halogenated azaindole. Background Art
[0002] Azaindole is an important class of heterocyclic compounds, similar in structure to indole and purine, and is the core fragment of many drugs. Azaindole derivatives have the activity of inhibiting multiple proteases, thus having potential biologically active uses and medicinal value, and are widely used in drug research.
[0003] 5-Halogenated azaindole is an important unit in many drug molecules and a very important class of drug intermediates with high research value. 5-Bromo-4,7-diazaindole is a key raw material for the preparation of JAK1 selective inhibitor upadacitinib; 5-Bromo-7-azaindole can be used in the preparation of anti-tumor drug vemurafenib; 5-Chloro-7-azaindole is a key fragment of piricitinib.
[0004]
[0005] At present, many methods for the preparation of 5-halogenated azaindoles have been reported, but most of them use a large amount of strong acid and strong base, resulting in a lot of waste; the prepared intermediates have poor stability, resulting in low product yield, poor product quality, and high industrial production costs.
[0006] Patent CN112574218 discloses a preparation of 5-halogenated azaindole, and its synthetic route is as follows:
[0007]
[0008] This method has a long process, and compound 2 is easily polymerized under alkaline conditions, resulting in a total yield of only more than 80% from raw material 1 to product 4.
[0009] Patent CN101817823 discloses a method for preparing 4,7-diazaindole and its 5-substitution product, and the synthesis route is as follows:
[0010]
[0011] This method uses a large amount of strong base, which causes the compound 2 to polymerize in the system. The total yield of this preparation method is less than 60%, resulting in a large amount of material waste and the generation of a large amount of alkaline wastewater.
[0012] Patent CN109575019 discloses a method for preparing 5-bromo-7-azaindole, and its synthetic route is as follows:
[0013]
[0014] This method has a short route, but because the alkynyl protected by isopropanol is difficult to remove the protecting group, the process requires a large amount of high-concentration liquid alkali and needs to be carried out under negative pressure. It has high requirements on production conditions and the process will produce a large amount of alkaline wastewater.
[0015] Patent CN104557917 discloses a method for synthesizing 5-halogenated-7-azaindole, and the synthetic route is as follows:
[0016]
[0017] In this method, 2-nitro-3-methyl-5-halopyridine needs 2-amino-3-methylpyridine to be prepared in two steps, the yields of the subsequent two steps are low, and the total yield of the latter two steps is less than 60%, there are many wastes, and the preparation cost is high.
[0018] Patent CN101815712 discloses a method for synthesizing 5-bromo-7-azaindole, and the synthetic route is as follows:
[0019]
[0020] In the first step of this method, three times the equivalent of the substrate is used as a strong base, potassium tert-butoxide, and a large amount of hydrochloric acid is then used, resulting in a serious problem of three wastes.
[0021] In summary, the existing 5-halogenated azaindole preparation methods have the following problems: the process route is long and the yield is low; or the process route is short but a large amount of strong acid and strong base are used, the process waste is serious, and the scale-up production of the product is affected. In view of this, it is still necessary to study the preparation method of 5-halogenated azaindole to overcome the defects of the above preparation process. Summary of the invention
[0022] In order to solve the defects and shortcomings of the above-mentioned prior art, the purpose of the present invention is to provide a method for preparing 5-halogenated azaindole. Compared with the existing method for preparing 5-halogenated azaindole, the preparation method of the present invention is simple, has mild reaction conditions, high product yield, avoids the use of a large amount of strong acid and strong base, and realizes green and environmental protection of industrial production.
[0023] In order to achieve the above object, the present invention provides the following technical solutions:
[0024] The present invention provides a method for preparing 5-halogenated azaindole, comprising the following steps:
[0025]
[0026] (1) Compound A and Compound B are dissolved in a solvent, and reacted at a certain temperature under the catalysis of an inorganic base or a basic salt to prepare Compound C;
[0027] (2) Compound C is reacted in a dilute acid to prepare compound D, i.e., 5-halogenated azaindole.
[0028] in,
[0029] X is one of Cl and Br; Y is one of C and N.
[0030] R1 and R2 are independently selected from methyl, ethyl, propyl, oxygen-substituted C1-C3, and N-substituted C1-C3. R1 and R2 are connected to each other to form a ring or not.
[0031] Preferably, the inorganic base or basic salt described in step (1) is selected from one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methoxide, sodium ethoxide, sodium tert-butoxide and potassium tert-butoxide.
[0032] Preferably, compound B is selected from at least one of dimethylamine, diethylamine, morpholine, tetrahydropyrrole, piperidine and N-methylpiperazine.
[0033] Preferably, in step (1), the molar ratio of compound A to compound B is 1:1 to 1:3.
[0034] Preferably, the solvent in step (1) is selected from one or more of water, methanol, ethanol, propanol, butanol, ethylene glycol and propylene glycol.
[0035] Preferably, the mass ratio of the amount of the inorganic base or basic salt to compound A in step (1) is 0.01% to 5%.
[0036] Preferably, the certain temperature in step (1) is 10°C to 60°C.
[0037] Preferably, the acid in step (2) is selected from one or more of sulfuric acid, hydrochloric acid and acetic acid.
[0038] Preferably, the concentration of the dilute acid in step (2) is 0.1 mol / L to 10 mol / L.
[0039] Preferably, the pH value of the reaction in step (2) is controlled at 5-6.
[0040] Preferably, compound A can be prepared according to the reported method disclosed in Organometallics 2010, 29, 998-1003:
[0041]
[0042] Preferably, a method for preparing 5-halogenated azaindole comprises the following steps:
[0043]
[0044] (1) Compound A and Compound B are dissolved in a solvent, and reacted at 10° C. to 60° C. under the catalysis of an inorganic base or a basic salt to prepare Compound C;
[0045] (2) Compound C is reacted in a dilute acid to prepare compound D, i.e., 5-halogenated azaindole.
[0046] in,
[0047] X is one of Cl and Br; Y is one of C and N; compound B is at least one selected from dimethylamine, diethylamine, morpholine, tetrahydropyrrole, piperidine, and N-methylpiperazine;
[0048] in,
[0049] The inorganic base or basic salt described in step (1) is selected from one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methoxide, sodium ethoxide, sodium tert-butoxide, and potassium tert-butoxide; the mass ratio of the inorganic base or basic salt to compound A is 0.01% to 5%;
[0050] The acid in step (2) is selected from one or more of sulfuric acid, hydrochloric acid, and acetic acid; the concentration of the dilute acid is 0.1 mol / L to 10 mol / L.
[0051] The preparation method of 5-halogenated azaindole of the present invention reduces the reaction steps by optimizing the process, directly uses TMS alkyne and amine to prepare the enamine intermediate in one step, greatly reduces the amount of alkali used in the first step reaction, is conducive to the generation of the product, avoids the polymerization reaction of alkyne byproducts under alkaline conditions, is conducive to the reaction, and the reduction in the amount of alkali also avoids the generation of a large amount of alkaline wastewater. At the same time, in the second step reaction, a trace amount of dilute acid can promote the occurrence of the reaction, the reaction conditions are mild, the reaction yield is high, the product quality is good, the method is simple, and green and environmental protection of industrial production is achieved. DETAILED DESCRIPTION
[0052] In order to enable those skilled in the art to better understand the technical solution of the present invention, some non-limiting embodiments are further disclosed below to further illustrate the present invention in detail.
[0053] The experimental methods of the present invention, unless otherwise specified, are all conventional technical methods in the art and are performed in accordance with the technical conditions described in professional literature or relevant product instructions; the materials, reagents, etc. used, unless otherwise specified, can be obtained from commercial channels.
[0054] Example 1: Preparation of 5-bromo-3-((trimethylsilyl)ethynyl)pyrazine-2-amine (a1)
[0055]
[0056] In a 20L reactor, add 2-aminopyrazine (1000g), DMSO (8L, 10v,v / m), purified water (1L, 1v,v / m), cool to -5 to 0°C, start adding NBS (4300g) in batches, control the temperature below 15°C, control the temperature at 5 to 15°C after addition, react, control in HPLC, the reaction is over, control the temperature at 5 to 15°C, add 2L of sodium sulfite (389g) aqueous solution dropwise to quench the reaction, cool to 5 to 10°C, filter, and rinse with 2L of purified water. , a crude wet product was obtained; the crude product was transferred to a 20L reactor, 8L of ethanol and 150g of activated carbon were added, decolorized at 50 to 55°C for 1h, filtered, and the filtrate was concentrated under reduced pressure at 45°C to remove half of the solvent, the temperature was raised to 55 to 60°C, stirred to dissolve, 8L of purified water was added dropwise, the temperature was naturally lowered for crystallization, stirred at 15 to 25°C for 1h, cooled to 0 to 5°C, centrifuged to obtain a wet product, and dried in vacuo at 45°C for 8 hours to obtain 2.35Kg of light yellow solid powder, with a yield of 89.1% and a purity of 99.61%.
[0057] In a 50L reactor, add 2-amino-3,5-dibromopyrazine (5.01Kg), tetrahydrofuran (30.2Kg, 6w / w), triethylamine (6.15Kg, 3.05eq), replace with argon, add tetrakis(triphenylphosphine)palladium (46.0g, 0.002eq), cuprous iodide (46.0g, 0.012eq), replace with nitrogen; cool to below 20°C, control the temperature below 25°C, add a mixture of trimethylsilyl acetylene (2.07Kg, 1.1eq) and tetrahydrofuran (4.03Kg, 0.8w / w), keep the temperature at 20 to 25°C for reaction, and then add HPL C control, the reaction is terminated when the peak area of 2-amino-3,5-dibromopyrazine accounts for ≤2.0%; the temperature is lowered to below 5°C, centrifuged, and the filter cake is rinsed with tetrahydrofuran (4.0Kg); the filtrate is concentrated under reduced pressure at 40±5°C until no liquid is evaporated, 2L of isopropanol is added and dragged until no liquid is evaporated, 5.92Kg of isopropanol is added, the temperature is raised to 50 to 55°C and pulped for 30 minutes, the temperature is lowered to 0°C and centrifuged to obtain a wet product, which is vacuum dried at 40 to 45°C for 8 hours to obtain 4.76Kg of 5-bromo-3-((trimethylsilyl)ethynyl)pyrazine-2-amine (a1) with a purity of 98.49% and a yield of 89.3%.
[0058] Example 2: Preparation of 5-chloro-3-((trimethylsilyl)ethynyl)pyridin-2-amine (a2)
[0059]
[0060] (1) In a 2L reactor, add 100g of 5-chloro-2-aminopyridine, DMSO (800mL, 10v, v / m), and purified water (100mL, 1v, v / m), cool to -5 to 0°C, start adding NBS (166g) in batches, control the temperature below 15°C, and react at 5 to 15°C after addition. Control the reaction in HPLC. When the reaction is complete, control the temperature at 5 to 15°C and add 200mL dropwise. The reaction was quenched with a 10% aqueous sodium sulfite solution, cooled to 5 to 10°C, filtered, rinsed with 200 mL of purified water to obtain a crude wet product; the crude product was transferred to a 2L reaction bottle, 800 mL of ethanol and 15 g of activated carbon were added, decolorized at 50 to 55°C for 1 h, filtered, the filtrate was concentrated under reduced pressure at 45°C to remove half of the solvent, the temperature was raised to 55 to 60°C, stirred to dissolve, 800 mL of purified water was added dropwise, the temperature was naturally lowered for crystallization, stirred at 15 to 25°C for 1 h, cooled to 0 to 5°C, centrifuged to obtain a wet product, and dried in vacuo at 45°C for 8 hours to obtain 150.2 g of 2-amino-3-bromo-5-chloropyridine dry product, with a yield of 93.1% and a purity of 99.3%.
[0061] (2) In a 3L reaction bottle, add 150g of 2-amino-3-bromo-5-chloropyridine, tetrahydrofuran (900g, 6w / w), triethylamine (220g, 3.0eq), replace with nitrogen, add tetrakis(triphenylphosphine)palladium (1.5g, 1%wt), cuprous iodide (1.5g, 1%wt), replace with nitrogen; cool to below 20°C, control the temperature below 25°C, add a mixture of trimethylsilyl acetylene (78.1g, 1.1eq) and tetrahydrofuran (120g, 0.8w / w), and keep at 20 to 25°C. The mixture was reacted at room temperature and controlled by HPLC. After the reaction was complete, the temperature was lowered to below 5°C and centrifuged. The filter cake was rinsed with 100 g of tetrahydrofuran. The filtrate was concentrated under reduced pressure at 40±5°C until no liquid was evaporated. 200 g of isopropanol was added and dragged until no liquid was evaporated. 500 g of isopropanol was added, the temperature was raised to 50 to 55°C and pulped for 30 minutes. The temperature was lowered to 0°C and filtered to obtain a wet product. The wet product was dried in vacuo at 40 to 45°C to obtain 150.5 g of 5-chloro-3-((trimethylsilyl)ethynyl)pyridine-2-amine (a2) with a yield of 92.6% and a purity of 99.2%.
[0062] Example 3: Preparation of 5-bromo-4,7-diazaindole (d1)
[0063]
[0064] (1) Under nitrogen protection, 81.1 g of a1, 250 ml of anhydrous ethanol, 26.5 g of morpholine, and 0.8 g of potassium tert-butoxide were added to a 1 L three-necked reaction flask. The reaction was stirred at room temperature until complete. A large amount of yellow solid precipitated in the reaction flask. Part of the ethanol was recovered under reduced pressure, and 300 ml of purified water was added to slurry. The mixture was filtered and dried at 50° C. to obtain 82.4 g of bright yellow solid c1, with a yield of 96.3%.
[0065] MS(ESI,pos.ion)m / z:285.0[M+H]+, 287.0[M+2+H]+.
[0066] 1 H-NMR (400MHz, DMSO-d6) δ7.50(s,1H),7.34(d,J=12.9Hz,1H),6.18(s,2H),5.43(d,J=12.9Hz,1H),3.64(t,J=4.8Hz,4H),3.26(t,J=4.8Hz,4H).
[0067] (2) Under nitrogen protection, 72.1 g of acetic acid and 300 g of purified water were added to a 500 ml three-necked flask, and 2.4 g of the above-obtained c1 was added to the reaction flask and stirred at room temperature. After the reaction was complete, the filter cake was filtered and rinsed with 122 g of purified water. The filter cake was drained until almost no liquid flowed out. The extraction was continued for 5-10 minutes to obtain a light yellow solid wet product. The wet product was vacuum dried (55-60° C., -0.01 to -0.005 MPa), and the water content was measured by sampling and ≤0.5%. The material was collected to obtain 55.8 g of yellow powder solid d1 with a yield of 97.5% and a purity of 99.2%.
[0068] 1 H-NMR(400MHz,DMSO-d6)δ12.35(s,1H),8.35(s,1H),7.96(t,J=3.2Hz,1H),
[0069] 6.63 (dd, J=3.6, 1.8 Hz, 1H).
[0070] Example 4: Preparation of 5-bromo-4,7-diazaindole (d1)
[0071] Under nitrogen protection, 81.1 g a1, 250 ml anhydrous ethanol, 250 ml purified water, 26.5 g morpholine and 0.1 g potassium hydroxide were added to a 1L three-necked reaction flask. The reaction was stirred at 60°C until complete. 150 ml of ethanol was recovered under reduced pressure. 1N hydrochloric acid was added dropwise to the reaction flask to adjust the reaction pH to about 6.0. The reaction was stirred to complete the conversion. The temperature was cooled to room temperature and filtered. The filter cake was rinsed with 120 g purified water and dried until almost no liquid flowed out. The extraction was continued for 5-10 minutes to obtain a light yellow solid wet product. The wet product was vacuum dried (55-60°C, -0.01 to -0.005 MPa). The moisture content was ≤0.5% when sampled and the material was collected to obtain 56.8 g of a yellow powder solid d1 with a yield of 95.6% and a purity of 99.7%.
[0072] Example 5: Preparation of 5-bromo-4,7-diazaindole (d1)
[0073] Under nitrogen protection, at room temperature, to a 250mL three-necked reaction flask, add 27.0g a1, 81ml anhydrous ethanol, 10.97g diethylamine, and 0.27g sodium tert-butoxide. Stir at 25°C until the reaction is complete. Recover 60ml ethanol under reduced pressure, dropwise add 1N hydrochloric acid to the reaction flask, adjust the reaction pH to about 5.0, stir to complete the conversion, filter, rinse the filter cake with 40g purified water, and drain until almost no liquid flows out. Continue to drain for 5-10 minutes to obtain a light yellow solid wet product. The wet product is vacuum dried (55-60°C, -0.01 to -0.005Mpa). When the moisture content is ≤0.5% when sampling, collect the material to obtain 18.8g of yellow powder solid d1 with a yield of 94.9% and a purity of 99.2%.
[0074] Example 6: Preparation of 5-chloro-7-azaindole (d2)
[0075]
[0076] Under nitrogen protection, 112 g a2, 250 ml ethylene glycol, 142 g pyrrole, and 0.1 g potassium hydroxide were added to a 1L three-necked reaction flask. The reaction was stirred at room temperature until complete. 25% dilute sulfuric acid was added dropwise to the reaction flask, and the reaction pH was adjusted to about 5.5. The reaction was stirred to complete the conversion. The filter cake was rinsed with 150 g purified water and dried until almost no liquid flowed out. The extraction was continued for 5-10 minutes to obtain a yellow solid wet product. The wet product was vacuum dried (55-60°C, -0.01 to 0.005 MPa), and a sample was taken to measure the moisture content of ≤0.5% to obtain 71.3 g of yellow powder solid d2 with a yield of 93.4% and a purity of 99.5%.
[0077] 1 H-NMR (400MHz, DMSO-d6) δ 11.88 (s, 1H), 8.19 (d, J = 2.4Hz, 1H), 8.06 (d, J = 2.4Hz, 1H), 7.56 (d, J = 2.8Hz, 1H), 6.44 (d, J = 2.8Hz, 1H).
[0078] Example 7: Preparation of 5-chloro-7-azaindole (d2)
[0079] Under nitrogen protection, 112 g a2, 500 ml methanol, 73.1 g diethylamine and 0.1 g sodium hydroxide were added to a 1 L three-necked reaction flask. The reaction was stirred at 60 ° C until the reaction was complete. 10% dilute hydrochloric acid was added dropwise to the reaction flask, and the reaction pH was adjusted to about 5.5. The reaction was stirred to complete the conversion. The temperature was cooled to room temperature and filtered. The filter cake was rinsed with 150 g purified water and dried until almost no liquid flowed out. The extraction was continued for 5-10 minutes to obtain a yellow solid wet product. The wet product was vacuum dried (55-60 ° C, -0.01 to 0.005 MPa), and a sample was taken to measure the moisture content ≤0.5% to obtain 72.8 g of yellow solid powder d2 with a yield of 95.4% and a purity of 99.6%.
[0080] The method of the present invention has been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein within the content, spirit and scope of the present invention to implement and apply the technology of the present invention. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters. It is particularly important to point out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention.
Claims
1. A method for preparing 5-halogenated azaindole, characterized in that: The following steps are involved: (1) Compound A and Compound B are dissolved in a solvent, and reacted at a certain temperature under the catalysis of an inorganic base or a basic salt to prepare Compound C; (2) reacting compound C in a dilute acid to prepare compound D, i.e., 5-halogenated azaindole; in, X is one of Cl and Br; Y is one of C and N; R1 and R2 are independently selected from methyl, ethyl, propyl, oxygen-substituted C1-C3, and N-substituted C1-C3. R1 and R2 are connected to each other to form a ring or not.
2. The preparation method according to claim 1, characterized in that The inorganic base or basic salt described in step (1) is selected from one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methoxide, sodium ethoxide, sodium tert-butoxide and potassium tert-butoxide.
3. The preparation method according to claim 1, characterized in that The compound B is at least one selected from dimethylamine, diethylamine, morpholine, tetrahydropyrrole, piperidine and N-methylpiperazine.
4. The preparation method according to claim 1, characterized in that The molar ratio of compound A to compound B in step (1) is 1:1-3.
5. The preparation method according to claim 1, characterized in that The solvent described in step (1) is selected from one or more of water, methanol, ethanol, propanol, butanol, ethylene glycol and propylene glycol.
6. The preparation method according to claim 1, characterized in that The mass ratio of the amount of the inorganic base or basic salt used in step (1) to compound A is 0.01% to 5%.
7. The preparation method according to claim 1, characterized in that The certain temperature in step (1) is 10°C to 60°C.
8. The preparation method according to claim 1, characterized in that The acid described in step (2) is selected from one or more of sulfuric acid, hydrochloric acid and acetic acid.
9. The preparation method according to claim 1, characterized in that The concentration of the dilute acid in step (2) is 0.1 mol / L to 10 mol / L.
10. The preparation method according to claim 1, characterized in that The following steps are involved: (1) Compound A and Compound B are dissolved in a solvent, and reacted at 10° C. to 60° C. under the catalysis of an inorganic base or a basic salt to prepare Compound C; (2) Compound C is reacted in a dilute acid to prepare compound D, i.e., 5-halogenated azaindole. in, X is one of Cl and Br; Y is one of C and N; compound B is at least one selected from dimethylamine, diethylamine, morpholine, tetrahydropyrrole, piperidine, and N-methylpiperazine; in, The inorganic base or basic salt described in step (1) is selected from one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methoxide, sodium ethoxide, sodium tert-butoxide, and potassium tert-butoxide; the mass ratio of the inorganic base or basic salt to compound A is 0.01% to 5%; The acid in step (2) is selected from one or more of sulfuric acid, hydrochloric acid, and acetic acid; the concentration of the dilute acid is 0.1 mol / L to 10 mol / L.
Citation Information
Patent Citations
Pyrazole compounds and their use as RAF inhibitors
CN101815712A
Preparation method of 5-halogenated azacycloindole
CN104557917A
Synthetic method of indole or azabenzopyrrole compound
CN112574218A
